Giant Cell Glioblastoma — Trials

Giant Cell Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00014170	Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme	completed	Phase 2	92	National Cancer Institute (NCI)NIH	1	Jul 16, 2013	clinicaltrials
NCT01095094	Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma	terminated	Phase 2	19	Case Comprehensive Cancer CenterOTHER	1	Jun 10, 2013	clinicaltrials